Novo Nordisk’s Wegovy and copyright, both run by semaglutide, have revolutionized obesity therapy through unparalleled weight loss effects.Novo Nordisk A/S can be a Danish multinational pharmaceutical company headquartered in Bagsværd,[three] with production facilities in nine international locations and affiliates or offices in 5.By 2022 the re